(Q62105805)

English

EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

clinical trial

Statements

A Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of an Anti-human-T-lymphocyte Immune Globulin (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary Pulmonary Allograft(s) (English)
0 references
0 references
0 references
0 references
January 2005
0 references
January 2010
0 references
223
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit